Close

Novavax (NVAX) Reports Topline Data from Phase 2 Older Adult Trial for RSV F Vaccine Programs; Offers Update on Path Forward

Go back to Novavax (NVAX) Reports Topline Data from Phase 2 Older Adult Trial for RSV F Vaccine Programs; Offers Update on Path Forward

Novavax (NVAX) to Resume Trading at 4:35 PM ET

July 24, 2017 4:15 PM EDT

Novavax (NASDAQ: NVAX) to Resume Trading at 4:35 PM ET

... More

Novavax (NVAX) Halted, News Pending

July 24, 2017 4:01 PM EDT

Novavax (NASDAQ: NVAX) Halted, News Pending

... More